Get startedLog in
    Picture of Roche Holding AG logo

    ROP — Roche Holding AG News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: CHMP Recommends EU Approval Of Roche's Ocrevus For Children And Adolescents

    Picture of Roche Holding AG logoRoche Holding AG
    18/09/2026 11:46
    BRIEF-CHMP Recommends EU Approval Of Roche's Ocrevus For Children And Adolescents
    Sept 18 (Reuters) - Roche Holding AG ROPC.S:
    • CHMP RECOMMENDS EU APPROVAL OF ROCHE’S OCREVUS FOR CHILDREN AND ADOLESCENTS WITH RELAPSING MULTIPLE SCLEROSIS
    • ROCHE HOLDING AG - EMA CHMP RECOMMENDS APPROVAL OF OCREVUS IV FOR PAEDIATRIC RMS PATIENTS AGED 10 AND OLDER
    • ROCHE HOLDING AG - FINAL DECISION FROM EUROPEAN COMMISSION ON OCREVUS APPROVAL EXPECTED SOON
    • ROCHE HOLDING AG - OCREVUS DEMONSTRATES NON-INFERIORITY IN RELAPSE CONTROL AND SUPERIORITY OVER FINGOLIMOD IN PHASE III STUDY
    • ROCHE HOLDING AG - OCREVUS REDUCED RISK OF RELAPSES BY 48% COMPARED WITH FINGOLIMOD IN PAEDIATRIC MS
    Source text: ID:nGNE9Mn4d
    Further company coverage: ROPC.S

     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Roche Holding AG

    See all news